Breakthrough T1D Blog

Living with type 1 diabetes (T1D) involves much more than managing blood sugar.

Meet Breakthrough T1D advocate Jake Thompson from St. John’s, Newfoundland and Labrador.

If the Thiessen family had a motto, it would surely be “knowledge is power.” “The more you know, the better you understand, the less scared you are, really,” says mom Taryn.

The final steps have been taken, the fundraising totals are nearly in, and another incredible Breakthrough T1D Walk season is in the books.

Interest in cell therapies for type 1 diabetes (T1D) is growing, but most people still don’t have enough information to fully understand their options.

Mental health is an important part of living well with type 1 diabetes (T1D), yet it is often overlooked.

Researchers this week have reported encouraging new results from an early clinical trial testing gene-edited islet cells in a single adult with type 1 diabetes (T1D) in Sweden.

The American Diabetes Association (ADA) Scientific Sessions are one of the world’s largest gatherings of diabetes researchers, clinicians, and industry leaders.

A new Breakthrough T1D-funded clinical trial led by Drs. Ahmad Haidar and Melissa-Rosina Pasqua (McGill University), is exploring whether tirzepatide, a commonly used medication for type 2 diabetes, can improve automated insulin delivery (AID) systems.

To every delegate who walked the halls of Parliament this year, this blog is for you.